A piece appeared today describing new clinical trials.
CAMBRIDGE, Mass., Nov. 5 (UPI) — U.S. scientists say they are starting a trial of a medication designed to treat the neurochemical defect underlying Fragile X syndrome.
I’ve wondered about how suggestive Fragile X features are of the origin of autism. In 1998, I predicted that a language challenged group of individuals should feature larger brains. I discovered a large percentage of autistics do. Later I estimated that autistic males, if indeed they represent an ancient matrifocal protype, should have larger testicles. (Primates matrifocal promiscious social structures reveal males with large testes.)
I could find no evidence that studies had been conducted on autistic males to determine testicle size, except for Fragile X. Fragile X males display unusually large genitals.
I have no idea how this would relate to the medication intervention in clinical trials. Perhaps there is an gonadal hormone system component.
